1.360USD+1.50%Mkt Cap: 67.19M USDP/E: —Last update: 2026-06-01
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilas…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap67.19M USD
Enterprise Value39.78M USD
Revenue (TTM)596.64K USD
Gross Profit31.05K USD
Net Income (TTM)-12.00M USD
Revenue/Share0.0120 USD
Last Price1.360 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.16
PEG—
EV/EBITDA-3.08
EV/Revenue66.67
P/S112.20
P/B1.70
EPS (TTM)-0.23
EPS (Forward)-0.43
52W Range
1.17024% of range1.960
52W High1.960 USD
52W Low1.170 USD
Profitability
Gross Margin7.58%
Oper. Margin-1516.60%
EBITDA Margin0.00%
Profit Margin-2928.78%
ROE-28.85%
ROA-26.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.81M USD
CapEx (TTM)2.90K USD
FCF Margin-998.95%
FCF Yield-8.87%
Net Debt-27.16M USD
Net Debt/EBITDA2.11
Balance Sheet
Debt/Equity0.00
Current Ratio9.09
Quick Ratio8.91
Book Value/Sh0.8010 USD
Cash/Share0.5550 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)9.000 USD
Target Range6.000 USD – 11.00 USD
# Analysts3
Ownership
Shares Out.49.22M
Float42.26M
Insiders2.88%
Institutions11.04%
Short Interest
Short Ratio7.7d
Short % Float0.32%
Short % Out.0.31%
Shares Short153.34K
Short (prev mo.)168.02K
Technical
SMA 501.409 (-3.4%)
SMA 2001.409 (-3.5%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)23.26K
Avg Vol (10d)28.66K
Technical Indicators
RSI (14)42.7
MACD-0.0156
MACD Signal-0.0117
MACD Hist.-0.0039
BB Upper1.445 USD
BB Middle1.388 USD
BB Lower1.331 USD
BB Width8.23%
ATR (14)0.0424 USD
Vol Ratio (20d)1.05x